Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia
R Storb, HJ Deeg, J Whitehead, F Appelbaum, P Beatty, W Bensinger, CD Buckner, R Clift, K Doney, V Farewell, and et al.
We treated 93 patients who had acute nonlymphoblastic leukemia in the first remission or chronic myelocytic leukemia in the chronic phase (median age, 30 years) with high-dose cyclophosphamide and fractionated total-body irradiation, followed by infusion of marrow from an HLA-identical sibling. To evaluate postgrafting prophylaxis for graft versus host disease, we studied these patients in a sequential, prospective, randomized trial that compared the effect of a combination of methotrexate and cyclosporine (n = 43) with that of cyclosporine alone (n = 50). All patients had evidence of sustained engraftment. A significant reduction in the cumulative incidence of grades II to IV acute graft versus host disease was observed in the patients who received both methotrexate and cyclosporine (33 percent), as compared with those who were given cyclosporine alone (54 percent) (P = 0.014). Seven patients who received cyclosporine alone acquired grade IV acute graft versus host disease, as compared with none who received both methotrexate and cyclosporine. Thirty-five of the 43 patients given both methotrexate and cyclosporine and 31 of the 50 patients given cyclosporine are alive as of this writing, at 4 months to 2 years (median, 15 months); the actuarial survival rates in the two groups at 1.5 years were 80 percent and 55 percent, respectively (P = 0.042). We conclude that the combination of methotrexate and cyclosporine is superior to cyclosporine alone in the prevention of acute graft versus host disease after marrow transplantation for leukemia, and that this therapy may have a beneficial effect on long-term survival.
This article has been cited by other articles:
Nishiwaki, S., Terakura, S., Ito, M., Goto, T., Seto, A., Watanabe, K., Yanagisawa, M., Imahashi, N., Tsukamoto, S., Shimba, M., Ozawa, Y., Miyamura, K.
(2009). Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease. Blood
114: 3113-3116
[Abstract][Full Text]
Alousi, A. M., Weisdorf, D. J., Logan, B. R., Bolanos-Meade, J., Carter, S., DiFronzo, N., Pasquini, M., Goldstein, S. C., Ho, V. T., Hayes-Lattin, B., Wingard, J. R., Horowitz, M. M., Levine, J. E., on behalf of the Blood and Marrow Transplant Clini,
(2009). Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. Blood
114: 511-517
[Abstract][Full Text]
Mielcarek, M., Storer, B. E., Boeckh, M., Carpenter, P. A., McDonald, G. B., Deeg, H. J., Nash, R. A., Flowers, M. E. D., Doney, K., Lee, S., Marr, K. A., Furlong, T., Storb, R., Appelbaum, F. R., Martin, P. J.
(2009). Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. Blood
113: 2888-2894
[Abstract][Full Text]
Sorror, M. L., Storer, B. E., Maloney, D. G., Sandmaier, B. M., Martin, P. J., Storb, R.
(2008). Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia. Blood
111: 446-452
[Abstract][Full Text]
Sorror, M. L., Sandmaier, B. M., Storer, B. E., Maris, M. B., Baron, F., Maloney, D. G., Scott, B. L., Deeg, H. J., Appelbaum, F. R., Storb, R.
(2007). Comorbidity and Disease Status Based Risk Stratification of Outcomes Among Patients With Acute Myeloid Leukemia or Myelodysplasia Receiving Allogeneic Hematopoietic Cell Transplantation. JCO
25: 4246-4254
[Abstract][Full Text]
Chang, C., Storer, B. E., Scott, B. L., Bryant, E. M., Shulman, H. M., Flowers, M. E., Sandmaier, B. M., Witherspoon, R. P., Nash, R. A., Sanders, J. E., Bedalov, A., Hansen, J. A., Clurman, B. E., Storb, R., Appelbaum, F. R., Deeg, H. J.
(2007). Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders. Blood
110: 1379-1387
[Abstract][Full Text]
Leisenring, W. M., Martin, P. J., Petersdorf, E. W., Regan, A. E., Aboulhosn, N., Stern, J. M., Aker, S. N., Salazar, R. C., McDonald, G. B.
(2006). An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens. Blood
108: 749-755
[Abstract][Full Text]
Steinbach, W. J., Cramer, R. A. Jr., Perfect, B. Z., Asfaw, Y. G., Sauer, T. C., Najvar, L. K., Kirkpatrick, W. R., Patterson, T. F., Benjamin, D. K. Jr., Heitman, J., Perfect, J. R.
(2006). Calcineurin Controls Growth, Morphology, and Pathogenicity in Aspergillus fumigatus.. Eukaryot Cell
5: 1091-1103
[Abstract][Full Text]
Pagel, J. M., Appelbaum, F. R., Eary, J. F., Rajendran, J., Fisher, D. R., Gooley, T., Ruffner, K., Nemecek, E., Sickle, E., Durack, L., Carreras, J., Horowitz, M. M., Press, O. W., Gopal, A. K., Martin, P. J., Bernstein, I. D., Matthews, D. C.
(2006). 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission. Blood
107: 2184-2191
[Abstract][Full Text]
Sorror, M. L., Maris, M. B., Storb, R., Baron, F., Sandmaier, B. M., Maloney, D. G., Storer, B.
(2005). Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood
106: 2912-2919
[Abstract][Full Text]
Baron, F., Maris, M. B., Sandmaier, B. M., Storer, B. E., Sorror, M., Diaconescu, R., Woolfrey, A. E., Chauncey, T. R., Flowers, M. E.D., Mielcarek, M., Maloney, D. G., Storb, R.
(2005). Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning. JCO
23: 1993-2003
[Abstract][Full Text]
Sanders, J. E., Guthrie, K. A., Hoffmeister, P. A., Woolfrey, A. E., Carpenter, P. A., Appelbaum, F. R.
(2005). Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood
105: 1348-1354
[Abstract][Full Text]
Robien, K., Ulrich, C. M., Bigler, J., Yasui, Y., Gooley, T., Bruemmer, B., Potter, J. D., Radich, J. P.
(2004). Methylenetetrahydrofolate Reductase Genotype Affects Risk of Relapse after Hematopoietic Cell Transplantation for Chronic Myelogenous Leukemia. Clin. Cancer Res.
10: 7592-7598
[Abstract][Full Text]
Diaconescu, R., Flowers, C. R., Storer, B., Sorror, M. L., Maris, M. B., Maloney, D. G., Sandmaier, B. M., Storb, R.
(2004). Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood
104: 1550-1558
[Abstract][Full Text]
Sorror, M. L., Maris, M. B., Storer, B., Sandmaier, B. M., Diaconescu, R., Flowers, C., Maloney, D. G., Storb, R.
(2004). Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities. Blood
104: 961-968
[Abstract][Full Text]
Robien, K., Schubert, M. M., Bruemmer, B., Lloid, M. E., Potter, J. D., Ulrich, C. M.
(2004). Predictors of Oral Mucositis in Patients Receiving Hematopoietic Cell Transplants for Chronic Myelogenous Leukemia. JCO
22: 1268-1275
[Abstract][Full Text]
Guardiola, P., Socie, G., Li, X., Ribaud, P., Devergie, A., Esperou, H., Richard, P., Traineau, R., Janin, A., Gluckman, E.
(2004). Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood
103: 73-77
[Abstract][Full Text]
Fukuda, T., Hackman, R. C., Guthrie, K. A., Sandmaier, B. M., Boeckh, M., Maris, M. B., Maloney, D. G., Deeg, H. J., Martin, P. J., Storb, R. F., Madtes, D. K.
(2003). Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood
102: 2777-2785
[Abstract][Full Text]
Mielcarek, M., Martin, P. J., Leisenring, W., Flowers, M. E. D., Maloney, D. G., Sandmaier, B. M., Maris, M. B., Storb, R.
(2003). Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood
102: 756-762
[Abstract][Full Text]
Radich, J. P., Gooley, T., Bensinger, W., Chauncey, T., Clift, R., Flowers, M., Martin, P., Slattery, J., Sultan, D., Appelbaum, F. R.
(2003). HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen. Blood
102: 31-35
[Abstract][Full Text]
Murata, M., Warren, E. H., Riddell, S. R.
(2003). A Human Minor Histocompatibility Antigen Resulting from Differential Expression due to a Gene Deletion. JEM
197: 1279-1289
[Abstract][Full Text]
Storek, J., Viganego, F., Dawson, M. A., Herremans, M. M. P. T., Boeckh, M., Flowers, M. E. D., Storer, B., Bensinger, W. I., Witherspoon, R. P., Maloney, D. G.
(2003). Factors affecting antibody levels after allogeneic hematopoietic cell transplantation. Blood
101: 3319-3324
[Abstract][Full Text]
Sackstein, R., Messina, J. L., Elfenbein, G. J.
(2003). In vitro adherence of lymphocytes to dermal endothelium under shear stress: implications in pathobiology and steroid therapy of acute cutaneous GVHD. Blood
101: 771-778
[Abstract][Full Text]
Storb, R. F., Lucarelli, G., McSweeney, P. A., Childs, R. W.
(2003). Hematopoietic Cell Transplantation for Benign Hematological Disorders and Solid Tumors. ASH Education Book
2003: 372-397
[Abstract][Full Text]
Ringden, O., Labopin, M., Bacigalupo, A., Arcese, W., Schaefer, U.W., Willemze, R., Koc, H., Bunjes, D., Gluckman, E., Rocha, V., Schattenberg, A., Frassoni, F.
(2002). Transplantation of Peripheral Blood Stem Cells as Compared With Bone Marrow From HLA-Identical Siblings in Adult Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia. JCO
20: 4655-4664
[Abstract][Full Text]
Svahn, B.-M., Remberger, M., Myrback, K.-E., Holmberg, K., Eriksson, B., Hentschke, P., Aschan, J., Barkholt, L., Ringden, O.
(2002). Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood
100: 4317-4324
[Abstract][Full Text]
Mohty, M., Kuentz, M., Michallet, M., Bourhis, J.-H., Milpied, N., Sutton, L., Jouet, J.-P., Attal, M., Bordigoni, P., Cahn, J.-Y., Boiron, J.-M., Blaise, D.
(2002). Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood
100: 3128-3134
[Abstract][Full Text]
Deeg, H. J., Storer, B., Slattery, J. T., Anasetti, C., Doney, K. C., Hansen, J. A., Kiem, H.-P., Martin, P. J., Petersdorf, E., Radich, J. P., Sanders, J. E., Shulman, H. M., Warren, E. H., Witherspoon, R. P., Bryant, E. M., Chauncey, T. R., Getzendaner, L., Storb, R., Appelbaum, F. R.
(2002). Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. Blood
100: 1201-1207
[Abstract][Full Text]
Mullighan, C. G., Heatley, S., Doherty, K., Szabo, F., Grigg, A., Hughes, T. P., Schwarer, A. P., Szer, J., Tait, B. D., Bik To, L., Bardy, P. G.
(2002). Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood
99: 3524-3529
[Abstract][Full Text]
Kiss, T.L., Abdolell, M., Jamal, N., Minden, M.D., Lipton, J.H., Messner, H.A.
(2002). Long-Term Medical Outcomes and Quality-of-Life Assessment of Patients With Chronic Myeloid Leukemia Followed at Least 10 Years After Allogeneic Bone Marrow Transplantation. JCO
20: 2334-2343
[Abstract][Full Text]
Carpenter, P. A., Appelbaum, F. R., Corey, L., Deeg, H. J., Doney, K., Gooley, T., Krueger, J., Martin, P., Pavlovic, S., Sanders, J., Slattery, J., Levitt, D., Storb, R., Woolfrey, A., Anasetti, C.
(2002). A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease. Blood
99: 2712-2719
[Abstract][Full Text]
Kansu, E., Gooley, T., Flowers, M. E. D., Anasetti, C., Deeg, H. J., Nash, R. A., Sanders, J. E., Witherspoon, R. P., Appelbaum, F. R., Storb, R., Martin, P. J.
(2001). Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial. Blood
98: 3868-3870
[Abstract][Full Text]
Matsuo, K., Suzuki, R., Morishima, Y., Hamajima, N., Ulrich, C. M., Storb, R., Schubert, M. M., Potter, J. D.
(2001). Attribution of posttransplantation toxicity to methotrexate regarding genotype of methylenetetrahydrofolate reductase gene (MTHFR) polymorphism needs further clarification. Blood
98: 2283-2283
[Full Text]
Remberger, M., Ringden, O., Blau, I.-W., Ottinger, H., Kremens, B., Kiehl, M. G., Aschan, J., Beelen, D. W., Basara, N., Kumlien, G., Fauser, A. A., Runde, V.
(2001). No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors. Blood
98: 1739-1745
[Abstract][Full Text]
Cavet, J., Dickinson, A. M., Norden, J., Taylor, P. R. A., Jackson, G. H., Middleton, P. G.
(2001). Interferon-{gamma} and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood
98: 1594-1600
[Abstract][Full Text]
Storek, J., Wells, D., Dawson, M. A., Storer, B., Maloney, D. G.
(2001). Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. Blood
98: 489-491
[Abstract][Full Text]
Ulrich, C. M., Yasui, Y., Storb, R., Schubert, M. M., Wagner, J. L., Bigler, J., Ariail, K. S., Keener, C. L., Li, S., Liu, H., Farin, F. M., Potter, J. D.
(2001). Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood
98: 231-234
[Abstract][Full Text]
Storek, J., Dawson, M. A., Storer, B., Stevens-Ayers, T., Maloney, D. G., Marr, K. A., Witherspoon, R. P., Bensinger, W., Flowers, M. E. D., Martin, P., Storb, R., Appelbaum, F. R., Boeckh, M.
(2001). Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood
97: 3380-3389
[Abstract][Full Text]
Witherspoon, R. P., Deeg, H. J., Storer, B., Anasetti, C., Storb, R., Appelbaum, F. R.
(2001). Hematopoietic Stem-Cell Transplantation for Treatment-Related Leukemia or Myelodysplasia. JCO
19: 2134-2141
[Abstract][Full Text]
Cwynarski, K., Ainsworth, J., Cobbold, M., Wagner, S., Mahendra, P., Apperley, J., Goldman, J., Craddock, C., Moss, P. A. H.
(2001). Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood
97: 1232-1240
[Abstract][Full Text]
Urbano-Ispizua, A., Rozman, C., Pimentel, P., Solano, C., de la Rubia, J., Brunet, S., Perez-Oteiza, J., Ferra, C., Zuazu, J., Caballero, D., Carvalhais, A., Diez, J. L., Espigado, I., Martinez, C., Campilho, F., Sanz, M. A., Sierra, J., Garcia-Conde, J., Montserrat, E.
(2001). The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings. Blood
97: 383-387
[Abstract][Full Text]
Izeradjene, K., Revillard, J.-P., Genestier, L.
(2001). Inhibition of thymidine synthesis by folate analogues induces a Fas-Fas ligand-independent deletion of superantigen-reactive peripheral T cells. Int Immunol
13: 85-93
[Abstract][Full Text]
Valks, R., Fernandez-Herrera, J., Bartolome, B., Fraga, J., Dauden, E., Garcia-Diez, A.
(2001). Late Appearance of Acute Graft-vs-Host Disease After Suspending or Tapering Immunosuppressive Drugs. Arch Dermatol
137: 61-65
[Abstract][Full Text]
Tiberghien, P., Ferrand, C., Lioure, B., Milpied, N., Angonin, R., Deconinck, E., Certoux, J.-M., Robinet, E., Saas, P., Petracca, B., Juttner, C., Reynolds, C. W., Longo, D. L., Herve, P., Cahn, J.-Y.
(2001). Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood
97: 63-72
[Abstract][Full Text]
Thomson, B. G., Robertson, K. A., Gowan, D., Heilman, D., Broxmeyer, H. E., Emanuel, D., Kotylo, P., Brahmi, Z., Smith, F. O.
(2000). Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood
96: 2703-2711
[Abstract][Full Text]
Marshall, N. A., Howe, J. G., Formica, R., Krause, D., Wagner, J. E., Berliner, N., Crouch, J., Pilip, I., Cooper, D., Blazar, B. R., Seropian, S., Pamer, E. G.
(2000). Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation. Blood
96: 2814-2821
[Abstract][Full Text]
Greinix, H. T., Volc-Platzer, B., Kalhs, P., Fischer, G., Rosenmayr, A., Keil, F., Honigsmann, H., Knobler, R. M.
(2000). Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Blood
96: 2426-2431
[Abstract][Full Text]
Nash, R. A., Antin, J. H., Karanes, C., Fay, J. W., Avalos, B. R., Yeager, A. M., Przepiorka, D., Davies, S., Petersen, F. B., Bartels, P., Buell, D., Fitzsimmons, W., Anasetti, C., Storb, R., Ratanatharathorn, V.
(2000). Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood
96: 2062-2068
[Abstract][Full Text]
Locatelli, F., Bruno, B., Zecca, M., Van-Lint, M. T., McCann, S., Arcese, W., Dallorso, S., Di Bartolomeo, P., Fagioli, F., Locasciulli, A., Lawler, M., Bacigalupo, A.
(2000). Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial. Blood
96: 1690-1697
[Abstract][Full Text]
James, R. I., Warlick, C. A., Diers, M. D., Gunther, R., McIvor, R. S.
(2000). Mild preconditioning and low-level engraftment confer methotrexate resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity. Blood
96: 1334-1341
[Abstract][Full Text]
Glas, A. M., van Montfort, E. H. N., Storek, J., Green, E.-G. N., Drissen, R. P. M., Bechtold, V. J., Reilly, J. Z., Dawson, M. A., Milner, E. C. B.
(2000). B-cell-autonomous somatic mutation deficit following bone marrow transplant. Blood
96: 1064-1069
[Abstract][Full Text]
Mielcarek, M., Leisenring, W., Torok-Storb, B., Storb, R.
(2000). Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood
96: 1150-1156
[Abstract][Full Text]
Lin, M.-T., Tseng, L.-H., Frangoul, H., Gooley, T., Pei, J., Barsoukov, A., Akatsuka, Y., Hansen, J. A.
(2000). Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation. Blood
95: 3832-3839
[Abstract][Full Text]
Walters, M. C., Storb, R., Patience, M., Leisenring, W., Taylor, T., Sanders, J. E., Buchanan, G. E., Rogers, Z. R., Dinndorf, P., Davies, S. C., Roberts, I. A. G., Dickerhoff, R., Yeager, A. M., Hsu, L., Kurtzberg, J., Ohene-Frempong, K., Bunin, N., Bernaudin, F., Wong, W.-Y., Scott, J. P., Margolis, D., Vichinsky, E., Wall, D. A., Wayne, A. S., Pegelow, C., Redding-Lallinger, R., Wiley, J., Klemperer, M., Mentzer, W. C., Smith, F. O., Sullivan, K. M.
(2000). Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Blood
95: 1918-1924
[Abstract][Full Text]
Deeg, H. J., Shulman, H. M., Anderson, J. E., Bryant, E. M., Gooley, T. A., Slattery, J. T., Anasetti, C., Fefer, A., Storb, R., Appelbaum, F. R.
(2000). Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age. Blood
95: 1188-1194
[Abstract][Full Text]
Blaise, D., Kuentz, M., Fortanier, C., Bourhis, J. H., Milpied, N., Sutton, L., Jouet, J.-P., Attal, M., Bordigoni, P., Cahn, J.-Y., Boiron, J.-M., Schuller, M.-P., Moatti, J.-P., Michallet, M.
(2000). Randomized Trial of Bone Marrow Versus Lenograstim-Primed Blood Cell Allogeneic Transplantation in Patients With Early-Stage Leukemia: A Report From the Societe Francaise de Greffe de Moelle. JCO
18: 537-537
[Abstract][Full Text]
Martin, P. J., Rowley, S. D., Anasetti, C., Chauncey, T. R., Gooley, T., Petersdorf, E. W., van Burik, J.-A., Flowers, M. E.D., Storb, R., Appelbaum, F. R., Hansen, J. A.
(1999). A Phase I-II Clinical Trial to Evaluate Removal of CD4 Cells and Partial Depletion of CD8 Cells From Donor Marrow for HLA-Mismatched Unrelated Recipients. Blood
94: 2192-2199
[Abstract][Full Text]
Matthews, D. C., Appelbaum, F. R., Eary, J. F., Fisher, D. R., Durack, L. D., Hui, T. E., Martin, P. J., Mitchell, D., Press, O. W., Storb, R., Bernstein, I. D.
(1999). Phase I Study of 131I-Anti-CD45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome. Blood
94: 1237-1247
[Abstract][Full Text]
Ringden, O., Remberger, M., Runde, V., Bornhauser, M., Blau, I.W., Basara, N., Holig, K., Beelen, D.W., Hagglund, H., Basu, O., Ehninger, G., Fauser, A.A.
(1999). Peripheral Blood Stem Cell Transplantation From Unrelated Donors: A Comparison With Marrow Transplantation. Blood
94: 455-464
[Abstract][Full Text]
Guinan, E. C., Boussiotis, V. A., Neuberg, D., Brennan, L. L., Hirano, N., Nadler, L. M., Gribben, J. G.
(1999). Transplantation of Anergic Histoincompatible Bone Marrow Allografts. NEJM
340: 1704-1714
[Abstract][Full Text]
Strasser, S. I., Sullivan, K. M., Myerson, D., Spurgeon, C. L., Storer, B., Schoch, H. G., Murakami, C. S., McDonald, G. B.
(1999). Cirrhosis of the Liver in Long-Term Marrow Transplant Survivors. Blood
93: 3259-3266
[Abstract][Full Text]
Beelen, D. W., Elmaagacli, A., Muller, K.-D., Hirche, H., Schaefer, U. W.
(1999). Influence of Intestinal Bacterial Decontamination Using Metronidazole and Ciprofloxacin or Ciprofloxacin Alone on the Development of Acute Graft-Versus-Host Disease After Marrow Transplantation in Patients With Hematologic Malignancies: Final Results and Long-Term Follow-Up of an Open-Label Prospective Randomized Trial. Blood
93: 3267-3275
[Abstract][Full Text]
Ringden, O., Remberger, M., Ruutu, T., Nikoskelainen, J., Volin, L., Vindelov, L., Parkkali, T., Lenhoff, S., Sallerfors, B., Mellander, L., Ljungman, P., Jacobsen, N.
(1999). Increased Risk of Chronic Graft-Versus-Host Disease, Obstructive Bronchiolitis, and Alopecia With Busulfan Versus Total Body Irradiation: Long-Term Results of a Randomized Trial in Allogeneic Marrow Recipients With Leukemia. Blood
93: 2196-2201
[Abstract][Full Text]
Petersdorf, E. W., Gooley, T. A., Anasetti, C., Martin, P. J., Smith, A. G., Mickelson, E. M., Woolfrey, A. E., Hansen, J. A.
(1998). Optimizing Outcome After Unrelated Marrow Transplantation by Comprehensive Matching of HLA Class I and II Alleles in the Donor and Recipient. Blood
92: 3515-3520
[Abstract][Full Text]
Greinix, H. T., Volc-Platzer, B., Rabitsch, W., Gmeinhart, B., Guevara-Pineda, C., Kalhs, P., Krutmann, J., Honigsmann, H., Ciovica, M., Knobler, R. M.
(1998). Successful Use of Extracorporeal Photochemotherapy in the Treatment of Severe Acute and Chronic Graft-Versus-Host Disease. Blood
92: 3098-3104
[Abstract][Full Text]
Stucki, A., Leisenring, W., Sandmaier, B. M., Sanders, J., Anasetti, C., Storb, R.
(1998). Decreased Rejection and Improved Survival of First and Second Marrow Transplants for Severe Aplastic Anemia (A 26-Year Retrospective Analysis). Blood
92: 2742-2749
[Abstract][Full Text]
Van Lint, M.T., Uderzo, C., Locasciulli, A., Majolino, I., Scime, R., Locatelli, F., Giorgiani, G., Arcese, W., Iori, A.P., Falda, M., Locatelli, F., Bosi, A., Miniero, R., Alessandrino, P., Dini, G., Rotoli, B., Bacigalupo, A.
(1998). Early Treatment of Acute Graft-Versus-Host Disease With High- or Low-Dose 6-Methylprednisolone: A Multicenter Randomized Trial From the Italian Group for Bone Marrow Transplantation. Blood
92: 2288-2293
[Abstract][Full Text]
Ratanatharathorn, V., Nash, R. A., Przepiorka, D., Devine, S. M., Klein, J. L., Weisdorf, D., Fay, J. W., Nademanee, A., Antin, J. H., Christiansen, N. P., van der Jagt, R., Herzig, R. H., Litzow, M. R., Wolff, S. N., Longo, W. L., Petersen, F. B., Karanes, C., Avalos, B., Storb, R., Buell, D. N., Maher, R. M., Fitzsimmons, W. E., Wingard, J. R.
(1998). Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation. Blood
92: 2303-2314
[Abstract][Full Text]
Nevill, T. J., Fung, H. C., Shepherd, J. D., Horsman, D. E., Nantel, S. H., Klingemann, H.-G., Forrest, D. L., Toze, C. L., Sutherland, H. J., Hogge, D. E., Naiman, S. C., Le, A., Brockington, D. A., Barnett, M. J.
(1998). Cytogenetic Abnormalities in Primary Myelodysplastic Syndrome Are Highly Predictive of Outcome After Allogeneic Bone Marrow Transplantation. Blood
92: 1910-1917
[Abstract][Full Text]
Morton, A. J., Gooley, T., Hansen, J. A., Appelbaum, F. R., Bruemmer, B., Bjerke, J. W., Clift, R., Martin, P. J., Petersdorf, E. W., Sanders, J. E., Storb, R., Sullivan, K. M., Woolfrey, A., Anasetti, C.
(1998). Association Between Pretransplant Interferon-alpha and Outcome After Unrelated Donor Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase. Blood
92: 394-401
[Abstract][Full Text]
Lucas, K. G., Burton, R. L., Zimmerman, S. E., Wang, J., Cornetta, K. G., Robertson, K. A., Lee, C. H., Emanuel, D. J.
(1998). Semiquantitative Epstein-Barr Virus (EBV) Polymerase Chain Reaction for the Determination of Patients at Risk for EBV-Induced Lymphoproliferative Disease After Stem Cell Transplantation. Blood
91: 3654-3661
[Abstract][Full Text]
Hansen, J. A., Gooley, T. A., Martin, P. J., Appelbaum, F., Chauncey, T. R., Clift, R. A., Petersdorf, E. W., Radich, J., Sanders, J. E., Storb, R. F., Sullivan, K. M., Anasetti, C.
(1998). Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid Leukemia. NEJM
338: 962-968
[Abstract][Full Text]
Yu, C., Seidel, K., Nash, R. A., Deeg, H. J., Sandmaier, B. M., Barsoukov, A., Santos, E., Storb, R.
(1998). Synergism Between Mycophenolate Mofetil and Cyclosporine in Preventing Graft-Versus-Host Disease Among Lethally Irradiated Dogs Given DLA-Nonidentical Unrelated Marrow Grafts. Blood
91: 2581-2587
[Abstract][Full Text]
Rambaldi, A., Borleri, G., Dotti, G., Bellavita, P., Amaru, R., Biondi, A., Barbui, T.
(1998). Innovative Two-Step Negative Selection of Granulocyte Colony-Stimulating Factor-Mobilized Circulating Progenitor Cells: Adequacy for Autologous and Allogeneic Transplantation. Blood
91: 2189-2196
[Abstract][Full Text]
Locasciulli, A., Testa, M., Valsecchi, M. G., Vecchi, L., Longoni, D., Sparano, P., Rovelli, A., Uderzo, C., Masera, G., Alberti, A.
(1997). Morbidity and Mortality Due to Liver Disease in Children Undergoing Allogeneic Bone Marrow Transplantation: A 10-Year Prospective Study. Blood
90: 3799-3805
[Abstract][Full Text]
Harousseau, J.-L., Cahn, J.-Y., Pignon, B., Witz, F., Milpied, N., Delain, M., Lioure, B., Lamy, T., Desablens, B., Guilhot, F., Caillot, D., Abgrall, J.-F., Francois, S., Briere, J., Guyotat, D., Casassus, P., Audhuy, B., Tellier, Z., Hurteloup, P., Herve, P.
(1997). Comparison of Autologous Bone Marrow Transplantation and Intensive Chemotherapy as Postremission Therapy in Adult Acute Myeloid Leukemia. Blood
90: 2978-2986
[Abstract][Full Text]
Higano, C. S., Chielens, D., Raskind, W., Bryant, E., Flowers, M. E.D., Radich, J., Clift, R., Appelbaum, F.
(1997). Use of alpha -2a-Interferon to Treat Cytogenetic Relapse of Chronic Myeloid Leukemia After Marrow Transplantation. Blood
90: 2549-2554
[Abstract][Full Text]
Rodriguez-Inigo, E., Tomas, J.-F., Gomez-Garcia de Soria, V., Bartolome, J., Pinilla, I., Amaro, M.-J., Carreno, V., Fernandez-Ranada, J.-M.
(1997). Hepatitis C and G Virus Infection and Liver Dysfunction After Allogeneic Bone Marrow Transplantation: Results From a Prospective Study. Blood
90: 1326-1331
[Abstract][Full Text]
Deeg, H. J., Lin, D., Leisenring, W., Boeckh, M., Anasetti, C., Appelbaum, F. R., Chauncey, T. R., Doney, K., Flowers, M., Martin, P., Nash, R., Schoch, G., Sullivan, K. M., Witherspoon, R. P., Storb, R.
(1997). Cyclosporine or Cyclosporine Plus Methylprednisolone for Prophylaxis of Graft-Versus-Host Disease: A Prospective, Randomized Trial. Blood
89: 3880-3887
[Abstract][Full Text]
Storek, J., Witherspoon, R. P., Maloney, D. G., Chauncey, T. R., Storb, R.
(1997). Improved Reconstitution of CD4 T Cells and B Cells But Worsened Reconstitution of Serum IgG Levels After Allogeneic Transplantation of Blood Stem Cells Instead of Marrow. Blood
89: 3891-3892
[Full Text]
Keil, F., Haas, O. A., Fritsch, G., Kalhs, P., Lechner, K., Mannhalter, C., Reiter, E., Niederwieser, D., Hoecker, P., Greinix, H. T.
(1997). Donor Leukocyte Infusion for Leukemic Relapse After Allogeneic Marrow Transplantation: Lack of Residual Donor Hematopoiesis Predicts Aplasia. Blood
89: 3113-3117
[Abstract][Full Text]
Storb, R., Yu, C., Wagner, J. L., Deeg, H. J., Nash, R. A., Kiem, H.-P., Leisenring, W., Shulman, H.
(1997). Stable Mixed Hematopoietic Chimerism in DLA-Identical Littermate Dogs Given Sublethal Total Body Irradiation Before and Pharmacological Immunosuppression After Marrow Transplantation. Blood
89: 3048-3054
[Abstract][Full Text]
Slattery, J.T., Clift, R.A., Buckner, C.D., Radich, J., Storer, B., Bensinger, W.I., Soll, E., Anasetti, C., Bowden, R., Bryant, E., Chauncey, T., Deeg, H.J., Doney, K.C., Flowers, M., Gooley, T., Hansen, J.A., Martin, P.J., McDonald, G.B., Nash, R., Petersdorf, E.W., Sanders, J.E., Schoch, G., Stewart, P., Storb, R., Sullivan, K.M., Thomas, E.D., Witherspoon, R.P., Appelbaum, F.R.
(1997). Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation. Blood
89: 3055-3060
[Abstract][Full Text]
Haddad, E., Sulis, M.-L., Jabado, N., Blanche, S., Fischer, A., Tardieu, M.
(1997). Frequency and Severity of Central Nervous System Lesions in Hemophagocytic Lymphohistiocytosis. Blood
89: 794-800
[Abstract][Full Text]
Petersdorf, E. W., Longton, G. M., Anasetti, C., Mickelson, E. M., Smith, A. G., Martin, P. J., Hansen, J. A.
(1996). Definition of HLA-DQ as a transplantation antigen. Proc. Natl. Acad. Sci. USA
93: 15358-15363
[Abstract][Full Text]
Nash, R. A., Gooley, T., Davis, C., Appelbaum, F. R.
(1996). The Problem of Thrombocytopenia after Hematopoietic Stem Cell Transplantation. The Oncologist
1: 371-380
[Abstract][Full Text]
Walters, M. C., Patience, M., Leisenring, W., Eckman, J. R., Scott, J. P., Mentzer, W. C., Davies, S. C., Ohene-Frempong, K., Bernaudin, F., Matthews, D. C., Storb, R., Sullivan, K. M.
(1996). Bone Marrow Transplantation for Sickle Cell Disease. NEJM
335: 369-376
[Abstract][Full Text]
Goulmy, E., Schipper, R., Pool, J., Blokland, E., Falkenburg, F., Vossen, J., Gratwohl, A., Vogelsang, G. B., van Houwelingen, H. C., van Rood, J. J.
(1996). Mismatches of Minor Histocompatibility Antigens between HLA-Identical Donors and Recipients and the Development of Graft-Versus-Host Disease after Bone Marrow Transplantation. NEJM
334: 281-285
[Abstract][Full Text]
Schlesinger, N., Huppert, A., Hoch, S., Malleson, P., Steinberg, A. D., Rosh, J. R., Birnbaum, A. H., van de Rijn, M., Kamel, O. W., Storb, R., Thomas, E. D., Tugwell, P., Yocum, D., Pincus, T., Wells, G.
(1995). Cyclosporine and Methotrexate for Severe Rheumatoid Arthritis. NEJM
333: 1567-1569
[Full Text]
Begovich, A. B., Erlich, H. A.
(1995). HLA Typing for Bone Marrow Transplantation: New Polymerase Chain Reaction--Based Methods. JAMA
273: 586-591
[Abstract]
Armitage, J. O.
(1994). Bone Marrow Transplantation. NEJM
330: 827-838
[Full Text]
Porter, D. L., Roth, M. S., McGarigle, C., Ferrara, J., Antin, J. H.
(1994). Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid Leukemia. NEJM
330: 100-106
[Abstract][Full Text]
Chao, N. J., Schmidt, G. M., Niland, J. C., Amylon, M. D., Dagis, A. C., Long, G. D., Nademanee, A. P., Negrin, R. S., O'Donnell, M. R., Parker, P. M., Smith, E. P., Snyder, D. S., Stein, A. S., Wong, R. M., Blume, K. G., Forman, S. J.
(1993). Cyclosporine, Methotrexate, and Prednisone Compared with Cyclosporine and Prednisone for Prophylaxis of Acute Graft-versus-Host Disease. NEJM
329: 1225-1230
[Abstract][Full Text]
Bortin, M. M., Horowitz, M. M., Gale, R. P., Barrett, A. J., Champlin, R. E., Dicke, K. A., Gluckman, E., Kolb, H.-J., Marmont, A. M., Mrsic, M., Sobocinski, K. A., Weiner, R. S., Rimm, A. A.
(1992). Changing Trends in Allogeneic Bone Marrow Transplantation for Leukemia in the 1980s. JAMA
268: 607-612
[Abstract]
Riddell, SR, Watanabe, K., Goodrich, J., Li, C., Agha, M., Greenberg, P.
(1992). Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science
257: 238-241
[Abstract]
Bortin, M. M., Horowitz, M. M., Rimm, A. A.
(1992). Increasing Utilization of Allogeneic Bone Marrow Transplantation: Results of the 1988-1990 Survey. ANN INTERN MED
116: 505-512
[Abstract]
Appelbaum, F. R., Barrall, J., Storb, R., Fisher, L. D., Schoch, G., Ramberg, R. E., Shulman, H., Anasetti, C., Bearman, S. I., Beatty, P., Bensinger, W. I., Buckner, C. D., Clift, R. A., Hansen, J. A., Martin, P., Petersen, F. B., Sanders, J. E., Singer, J., Stewart, P., Sullivan, K. M., Witherspoon, R. P., Thomas, E. D.
(1990). Bone Marrow Transplantation for Patients with Myelodysplasia: Pretreatment Variables and Outcome. ANN INTERN MED
112: 590-597
[Abstract]
Kernan, N. A., Byers, V., Scannon, P. J., Mischak, R. P., Brochstein, J., Flomenberg, N., Dupont, B., O'Reilly, R. J.
(1988). Treatment of Steroid-Resistant Acute Graft-vs-host Disease by In Vivo Administration of an Anti--T-Cell Ricin A Chain Immunotoxin. JAMA
259: 3154-3157
[Abstract]
Shannon, K. M., Cowan, M. J., Matthay, K. K.
(1987). Pediatric Bone Marrow Transplantation: Intensive Care Management. J Intensive Care Med
2: 328-344
[Abstract]
